Archive | MDMA

Sunday, June 12th, 2011

What’s Drug Dealer To Do?

United States v. Figueroa, No. 10-2050-cr (2d Cir. May 16, 2011) (Miner, Cabranes, Straub, CJJ)
Several months ago, in a per curiam, the court held that it was not error for a district court to treat the combination of BZP and TFMPP, which is commonly sold on the street as ecstasy, but for which there is no dedicated guideline, as ecstasy (“MDMA”) . This opinion deals with BZP alone, and reaches a different result.
Here, the defendants had about 20,000 pills containing BZP, combined with trace – the circuit called it “unmeasurable” – amounts of other substances, including TFMPP. The district court treated the pills as containing pure BZP, then analogized BZP to MDMA for guidelines purposes. The defense disputed this, and asked for a hearing, but the district court refused even that, relying on the DEA’s lab report and the fact that BZP is sold as MDMA on

Posted By
Categories: amphetamine, BZP, MDMA, Uncategorized

Continue Reading